Fundraising Fox
Medminder
Norwood, US · Founded 2007 · 99 employees on LinkedIn · 1 known investors
Find your way into Medminder
Sign up to see every warm intro you have to Medminder
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medminder team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MedMinder provides an integrated pharmacy, medication adherence, and connected care platform for healthcare providers, payors, and patients. The solution combines at-home pharmacy services, digital devices, and enterprise software to optimize medication management and improve healthcare outcomes.
Founders & leadership
TH
TROY HILSENROTHCEO `Troy Hilsenroth is an Executive Officer and Director at MedMinder, which provides pharmacy, medication adherence, and connected care solutions for healthcare providers, payors, and patients. He brings experience in domestic and international healthcare markets.
ES
Eran ShavelskyNamed on SEC filing
Board
UG
DC
SS
Sundar SubramaniamBoard director
BD
Ben DunnBoard director
DS
DAVID SHULKINBoard director
ME
Mona Eliassen-TaliaferroBoard director
HS
Hiram SamelBoard director
Investors · 1
Accelmed Partnerslisted by Accelmed PartnersMiami
How we know: Accelmed Partners's portfolio page · board seat on SEC Form D · privateequitywire.co.uk · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$60.8M disclosed across 7 of 8 rounds · 2012–2024
▶$11.5MraisedJan 2025 · 4 investors · Other Health CareRule 506(b)
▶$11.5MraisedJan 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- URI GEIGERDirector
- DANIEL COHENDirector
- SUNDAR SUBRAMANIAMDirector
- TROY HILSENROTHExecutive Officer, Director
- DAVID SHULKINDirector
- Offering amount
- $17.5M
- Amount sold
- $11.5M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedAug 2022 · 1 investors · Other Health CareRule 506(b)
▶$10MraisedAug 2022 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- URI GEIGERDirector
- WAYNE CAFRANDirector
- SUSAN O'SHEAExecutive Officer
- MICHAEL EDWARDSExecutive Officer, Director
- SUNDAR SUBRAMANIAMDirector
- MIKE NAPOLITANOExecutive Officer
- ALAN BURGOSExecutive Officer
- ERAN SHAVELSKYDirector
- FRANK SHEEHYDirector
- DAVID SHULKINDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedMar 2021 · 1 investors · Other Health CareRule 506(b)
▶$30MraisedMar 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank SheehyDirector
- Robert CartwrightExecutive Officer
- David ShulkinDirector
- Rafael TorgovickyDirector
- Uri GeigerDirector
- Eran ShavelskyExecutive Officer, Director
- Sundar SubramaniamDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.5MraisedSep 2019 · 8 investors · Other Health CareRule 506(b)
▶$6.5MraisedSep 2019 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eran ShavelskyExecutive Officer, Director
- Sundar SubramaniamDirector
- Ben DunnDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$610.2KraisedNov 2017 · 3 investors · Other Health CareRule 506(b)
▶$610.2KraisedNov 2017 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sundar SubramaniamDirector
- Eran ShavelskyExecutive Officer, Director
- Ben DunnDirector
- Offering amount
- $1.5M
- Amount sold
- $610.2K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedNov 2016 · 2 investors · Other Health CareRule 506(b)
▶$1.4MraisedNov 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sundar SubramaniamDirector
- Ben DunnDirector
- Eran ShavelskyExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$850KraisedMar 2012 · 1 investors · OtherRule 506(b)
▶$850KraisedMar 2012 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eran ShavelskyExecutive Officer, Director
- Mona Eliassen-TaliaferroDirector
- Ben DunnDirector
- Hiram SamelDirector
- Offering amount
- $850K
- Amount sold
- $850K
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Medminder do?
- MedMinder provides an integrated pharmacy, medication adherence, and connected care platform for healthcare providers, payors, and patients. The solution combines at-home pharmacy services, digital devices, and enterprise software to optimize medication management and improve healthcare outcomes.
- Who are Medminder's investors?
- Medminder's investors include Accelmed Partners.
- How much funding has Medminder raised?
- Medminder has disclosed $60.8M raised across 7 of its 8 known rounds.
- Where is Medminder headquartered?
- Medminder is headquartered in Norwood, US.